We Accelerate Discovery

You are here

Printer

Nanomedicine Roadmap Initiative

Project Launch Meeting, May 4, 2004
Purpose and Agenda

Purpose

The goals of the NIH Nanomedicine Roadmap Initiative are to 1) obtain a comprehensive set of measurements on molecules and assemblies of molecules, and use those measurements to understand molecular pathways and networks, and 2) use that knowledge to drive the design and development of new nanomachines and technologies to improve human health.

To launch this initiative, NIH will support Nanomedicine Development Centers. This public meeting was held to discuss the NIH vision for these Centers, receive comments from the scientific community, and announce the details of a new funding opportunity (RFA) for planning these Centers.

Agenda

Note: Slide presentations from the webcast can be viewed by clicking on the PDF icon under the session or speaker name.
 

8:00 a.m. Welcome Raynard Kington, Deputy Director, NIH Paul Sieving, Director, NEI
8:15 a.m. The NIH Roadmap and Nanomedicine Development Centers
Jeff Schloss, National Human Genome Research Institute
9:00 a.m. Session I: A Multidisciplinary Approach to Nanomedicine
An example of multiple scientific perspectives needed to elucidate and apply design principles for reverse engineering

Moderator: Catherine Lewis, National Institute of General Medical Sciences

Speakers:

Steve Goldstein, Yale University
Ion Channels: Nano-Mediators of Health, Disease and Therapy

Peter Agre, Johns Hopkins University
Aquaporin Water Channels: Structures and Functions

Hagan Bayley, University of Oxford, UK
Emerging Strategies for Engineering Channels and Pores

Eric Jakobsson, NIH and University of Illinois
Multiscale Simulations of Ion Channel Function Using Tools and Principles from Computational Chemistry and Device Design

10:45 a.m. Session II: Targets for Nanomedicine Research
A moderated discussion of additional examples of scientific target areas for Nanomedicine research

Moderator: Eleni Kousvelari, National Institute of Dental and Craniofacial Research

Discussion Leaders:
Carlo Montemagno, UCLA
James Baker, University of Michigan

1:15 p.m. Session III: Creating Nanomedicine Research Teams
A moderated discussion of strategies to establish Nanomedicine research teams

Moderators: Dan Gallahan, NCI; Kuan Wang, NIAMS

Panel members:
Denice Denton, University of Washington
Dean, College of Engineering

Ueli Aebi, Biozentrum,University of Basel
National Center of Competence in Research: Nanoscale Science

Chih-Ming Ho, UCLA
Institute for Cell Mimetic Space Exploration

Stuart Schreiber, Harvard University
Institute of Chemistry and Cell Biology

David Thomassen, US Department of Energy
DOE Genomes to Life Program

2:30 p.m. Session IV: Innovative Strategies for NIH Funding of Nanomedicine
Application Process and Timeline; New NIH funding authorities for Nanomedicine

Speaker: Richard S. Fisher, NEI

Up to Top